Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Novel EU-funded collaborative proteomics project to bring proteomics to clinical application


Novel proteomic technologies that are so robust and powerful that they can be used in every biological laboratory and in every clinic are expected as results of the currently starting research consortium MSmed. The European Commission is co-funding the project with 3.7 Million Euros for four years starting December 1, 2015 within the research line “Future and Emerging Technologies” under the Horizon 2020 Programme. MSmed will automate workflows in mass spectrometric analysis for proteomics research to prepare them for high-throughput clinical application.

Proteins are the major functional actors within cells and exert most of the cells’ functions. Over the past decade the analysis of the protein inventory of cells and tissues, the „proteome“, has made tremendous progress showing definite promise of mass spectrometry technology in the life sciences.

The MSMed team. Clockwise: Matthias Mann, Jesper Olsen, Albert Heck, Alexander Makarov und Jürgen Cox (middle).

© MPI of Biochemistry

To date proteome analysis is still a specialist technology and has not reached the robustness and availability for large-scale biomedical and clinical applications. In that respect it clearly lags behind genomic technologies that are, however, not applicable to protein based questions.

The MSmed project was initiated to tackle this issue. The vision of project coordinator Matthias Mann is “…to introduce proteome analysis by mass spectrometry as automated routine tool into the clinics”. Complementing current genetic methods with direct proteome analysis would allow measuring actual medical parameters as reflected in the patient’s proteome rather than solely genetic disposition.

Such a paradigm changing approach could transform personalized medicine, revolutionizing medical diagnosis and the assessment of efficacy of medical intervention on an individual basis.

To bring this vision into reality, a team was built around leaders in the proteomics field with a history of successful collaboration. They will bring in a broad range of experiences and expertise to master the various challenges lying ahead. These challenges include the development of novel instrumentation with drastically increased performance, the automation of sample preparation and analysis, the adaptation of analysis protocols to the characteristics of clinical samples, and the development of comprehensive software for extensive in-depth analysis of the large amounts of data obtained.

When successful, MSmed will establish mass spectrometry based proteomics in systems medicine, making all workflows and mass spectrometry platforms available to the community. These workflows will be used as the basis of myriad applications in biomedicine, even in the clinic. This in turn will lead to a new eco-system around improved diagnosis, elucidations of disease mechanisms and drug action.

The MSmed team
The coordinating Mann group (Novo Nordisk Foundation Center for Protein Research, University of Copenhagen and Max Planck Institute of Biochemistry, Martinsried), the Olsen group (Novo Nordisk Foundation Center for Protein Research, University of Copenhagen) , the Cox group (Max Planck Institute of Biochemistry, Martinsried), the Heck group (Utrecht University) and Makarov from the industrial partner Thermo Fisher Scientific, are all leaders in the field and have a longstanding collaboration concerning the improvement of instrumentation in mass spectrometry, with the aim to make it accessible to all researchers. One example is the earlier EU-funded project PROSPECTS, which was also coordinated by Matthias Mann, where Mann, Olsen, Cox and Makarov jointly invented novel technology for in depth quantitative proteomics and the EU-funded project PRIME-XS, coordinated by Albert Heck, wherein amongst others Mann and Olsen participated and jointly provided access to their facilities to researchers in Europe and performed joint research projects.

The coordinating center in Copenhagen brings in expertise in clinical approaches and a network of clinical collaborators. The Heck group (University Utrecht) is a key partner in technology development for novel identification methods to be used in the analysis of modified proteins. The Cox group (Max Planck Institute of Biochemistry, Martinsried) complements the lab expertise with high-end bioinformatics. Together with the Mann group they have developed the most successful and industry standard MaxQuant platform for proteomics research worldwide. Makarov, being the inventor of the leading mass analyser and research director at Thermo Fisher complements the team, and has long standing relationship with all the academic partners. These earlier achievements lend credibility to the future success of the MSmed project.

Dr. Anne Katrin Werenskiold
EU Office
Max-Planck-Institut für Biochemie
Am Klopferspitz 18
82152 Martinsried
Tel. +49 89 8578-2601

Dr. Christiane Menzfeld
Public Relations
Max Planck Institute of Biochemistry
Am Klopferspitz 18
82152 Martinsried
Tel. +49 89 8578-2824

Weitere Informationen: - homepage Max Planck Institute of Biochemistry

Dr. Christiane Menzfeld | Max-Planck-Institut für Biochemie

More articles from Awards Funding:

nachricht VDI presents International Bionic Award of the Schauenburg Foundation
26.10.2016 | Fraunhofer-Institut für Produktionstechnologie IPT

nachricht Changing the Energy Landscape: Affordable Electricity for All
20.10.2016 | Fraunhofer-Institut für Solare Energiesysteme ISE

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel light sources made of 2D materials

Physicists from the University of Würzburg have designed a light source that emits photon pairs. Two-photon sources are particularly well suited for tap-proof data encryption. The experiment's key ingredients: a semiconductor crystal and some sticky tape.

So-called monolayers are at the heart of the research activities. These "super materials" (as the prestigious science magazine "Nature" puts it) have been...

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Steering a fusion plasma toward stability

28.10.2016 | Power and Electrical Engineering

Bioluminescent sensor causes brain cells to glow in the dark

28.10.2016 | Life Sciences

Activation of 2 genes linked to development of atherosclerosis

28.10.2016 | Life Sciences

More VideoLinks >>>